Navigation Links
New Data Supports Significant Economic and Clinical Value of MENOPUR(R) in IVF
Date:6/30/2009

AMSTERDAM, The Netherlands, June 30 /PRNewswire/ --

- "Study Could Have Major Impact on the Decision-Making Process With Respect to Infertility Treatment"

New data from an economic analysis presented today at this year's European Society of Human Reproduction and Embryology (ESHRE) congress showed that, within the parameters of the simulation model used, the in vitro fertilisation (IVF) treatment MENOPUR (highly-purified human menopausal gonatropin or HP-hMG) offered considerable cost-savings over recombinant follicle stimulating hormone (rFSH).[1] The cost-effectiveness of HP-hMG compared with rFSH suggested by this data could make it a more attractive choice for use in infertility treatment within a fixed healthcare budget.

In today's difficult global financial situation, the cost-effectiveness of infertility treatments, such as IVF, is more important than ever. Experiencing fertility problems is deeply distressing and isolating for couples and the cost of treatment is one of many considerations for people seeking treatment. A recent audit of European infertility patient groups showed that infertile couples are calling for clear information on the cost-effectiveness, as well as the efficacy of individual treatments.[2]

HP-hMG and rFSH are two commonly used hormonal therapies belonging to the class of drugs known as gonadotropins that enhance egg production in IVF treatment. HP-hMG, contains both FSH and hCG-driven (human chorionic gonadotropin) LH-activity (luteinizing hormone). In contrast, rFSH is a recombinant product and contains only rFSH.

"Until recently, discussions regarding funding for infertility treatment services have been hindered by a relative paucity of economic studies of the specific treatments," points out study investigator Dr Jaro Wex from PharmArchitecture, UK.

"Our new study compared success rates and value for money of gonadot
'/>"/>

SOURCE Ferring Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
2. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
4. Cost-Effectiveness Study Supports Use of EUFLEXXA(TM) by Rheumatologists for Pain Relief in Patients with Knee Osteoarthritis
5. New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
6. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
7. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
8. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
9. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
10. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
11. New Clinical Data Further Supports Chromium Picolinates Role in Enhancing Brain Activity in Older Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... May 27, 2015  Vital Access Corp. announced today ... facility with Deerfield Management, a healthcare investment firm. Proceeds ... Access, continued global expansion of its innovative VWING™ Vascular ... Company,s proprietary vascular access platform. "Vital Access ... partner. Deerfield is a healthcare investor with great depth ...
(Date:5/27/2015)... N.Y. , May 27, 2015  VirtualScopics, ... of clinical trial imaging solutions, announced today, ahead ... Medicine (ISMRM) Annual Meeting in Toronto ... operational investments in Magnetic Resonance Elastography (MRE).  VirtualScopics, ... supporting pharmaceutical companies integrating MRE into their global, ...
(Date:5/27/2015)... LONDON and NEW ... - http://www.abmrg.com/Indonesia-Respiratory-Devices-and-Respiratory-Diagnostics-Market-through-2020---Detailed-analysis-of-Hospital-and-Retail-market.html - Over 70% ... - Around 400,000 Indonesians die annually due to smoking-related ... - Three-fourths of 6.5 million vehicles in ... Indonesia is the ...
Breaking Medicine Technology:Vital Access Receives $10 Million Financing Commitment from Deerfield 2Vital Access Receives $10 Million Financing Commitment from Deerfield 3VirtualScopics, Inc. Makes Investments In Magnetic Resonance Elastography (MRE) 2VirtualScopics, Inc. Makes Investments In Magnetic Resonance Elastography (MRE) 3VirtualScopics, Inc. Makes Investments In Magnetic Resonance Elastography (MRE) 4Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 2Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 3Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 4
... Nexcore Technologies, Inc. of Waldwick, an original ... acquired the Meditron line of gastroenterology endoscopy products from ... Frank, President & CEO of Nexcore Technologies, said the ... in gastroenterology endoscopy products, noting that the Meditron product ...
... Quark Pharmaceuticals, Inc., a pharmaceutical company engaged in the ... has dosed the first patient with recent onset of ... Phase I study of QPI-1007, the Company,s proprietary synthetic ... The Phase I open-label, dose-escalation study was initiated during ...
Cached Medicine Technology:Quark Pharmaceuticals Doses First Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Patient in Stratum II of its Clinical Study of siRNA Drug Candidate QPI-1007 2Quark Pharmaceuticals Doses First Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) Patient in Stratum II of its Clinical Study of siRNA Drug Candidate QPI-1007 3
(Date:5/27/2015)... Altec Products, Inc., a leader in ... Premier Sponsorship of Connections 2015. The all-day client conference ... May 28th and will deliver to clients both the ... roadmap to get there. , Arxis Technology, Inc. ... installation and support of Intacct Cloud Financials, Adaptive Insights, ...
(Date:5/27/2015)... Harbor, MD (PRWEB) May 27, 2015 ... will attend this year’s conference of the American Immigration ... at the Gaylord National Resort. MCA’s booth is #404. ... Annual Gathering in Immigration Law.” MCAads.com, a regular AILA ... family meeting” as they welcome current clients to their ...
(Date:5/27/2015)... Washington (PRWEB) May 27, 2015 ... a national non-profit and thought leader in research on ... the Bruises,” an online campaign uniting survivors, advocates, organizations, ... domestic violence on chronic disease. The campaign features ... violence survivors who struggle with chronic disease as a ...
(Date:5/27/2015)... 27, 2015 A. Joshua Halpern, MD, ... the addition of UltraShape® , a revolutionary body-shaping ... his Tampa Plastic Surgery Center. , ... the first and only non-invasive body shaping treatment that ... fat, without harming the surrounding tissue, vasculature, nerves or ...
(Date:5/27/2015)... The Case Management Society of America has ... Lifetime Achievement Award, to Anne Llewellyn RN-BC, MS, BHSA, ... at the association’s 25th Annual Conference and Expo at ... CMSA Board of Directors awards the Lifetime Achievement Award ... contribution to practice of case management and in support ...
Breaking Medicine News(10 mins):Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 2Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 3Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 2Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 3Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 2Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 3Health News:Tampa Plastic Surgery Center Delivers A Better Way To A Better Body 2Health News:Tampa Plastic Surgery Center Delivers A Better Way To A Better Body 3Health News:CMSA to Present Prestigious Lifetime Achievement Award to Anne Llewellyn RN-BC, MS, BHSA, CCM, CRRN 2
... 13 DKMS is proud to announce that they,will ... on,Wednesday, May 7th, 2008 at Capitale in New York ... raise money and awareness for DKMS, the,world,s largest marrow ... has helped facilitate more than 13,000 transplants., The ...
... Photo Therapeutics, Inc., leaders in light therapy, proudly receives its ... ... 12 Photo Therapeutics, Inc. is,pleased to announce it has received ... the treatment of,periorbital wrinkles., (Photo: http://www.newscom.com/cgi-bin/prnh/20080312/LAW011 ), Omnilux ...
... WASHINGTON, March 12 Today, the U.S.,Environmental Protection ... Air Quality Standard for ozone. We wish we,could be ... announced,today, although an improvement, falls far short of the ... celebrate half measures when the risks are,so evident, when ...
... Providence,Service Corporation (Nasdaq: PRSC ) today announced that ... of its common stock on Form S-3,with the Securities ... file the proposed shelf registration statement immediately,following the filing ... Year Ended,December 31, 2007; however, it has no immediate ...
... was,issued today by the National Quality Forum:h, ... Care,Coordination and 2008 Spring Membership Meeting. A full ... 26: Spring Membership Meeting. The membership meeting will ... the National Priorities,Partners, a group of 27 organizations ...
... PHILADELPHIA To foster interest in cancer research careers ... will provide an opportunity for 10 undergraduate students to ... 2008 through the AACR-Thomas J. Bardos Science Education Awards ... enhance the education of the students by providing financial ...
Cached Medicine News:Health News:Super Model Cindy Crawford will be Honored at DKMS 'Linked Against Leukemia Gala' on May 7th at Capitale 2Health News:Omnilux New-U(TM) Hand-Held Device Receives FDA Approval 2Health News:Statement of Bernadette Toomey, President and Chief Executive Officer, American Lung Association 2Health News:Statement of Bernadette Toomey, President and Chief Executive Officer, American Lung Association 3Health News:Providence Service Corporation Announces Intent to File a Common Stock Shelf Registration Statement 2Health News:National Quality Forum Spring Conference; Leaders in Healthcare Quality to Focus on National Priorities and Care Coordination 2Health News:AACR-Bardos Awards for Undergraduate Students announced 2
Inquire...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
... A fixed pipette is ... a single volume. Fixed volume ... and advantages as other Finnpipette ... design, Super blow-out (1-40ul), Soft-touch ...
500L...
Medicine Products: